PCN17 ESTIMATING THE COST SAVINGS FROM THE INTRODUCTION OF KRAS TESTING IN THE MANAGEMENT OF METASTATIC COLORECTAL CANCER (MCRC) PATIENTS RECEIVING PANITUMUMAB IN GREECE
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66554-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)66554-0/fulltext
Title :
PCN17 ESTIMATING THE COST SAVINGS FROM THE INTRODUCTION OF KRAS TESTING IN THE MANAGEMENT OF METASTATIC COLORECTAL CANCER (MCRC) PATIENTS RECEIVING PANITUMUMAB IN GREECE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66554-0&doi=10.1016/S1098-3015(10)66554-0
First page :
Section Title :
Open access? :
No
Section Order :
389